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NKT cells are CD1d-restricted T cells that ex-
press a conserved semi-invariant V14(huV24)-
J18/V8,7,2(huV11) TCR. They constitute 
a separate lineage of innate-like T cells emerg-
ing from thymic development as effector cells 
able to explosively release IL-4, IL-13, and also 
IFN- upon primary stimulation (Matsuda and 
Gapin, 2005; Bendelac et al., 2007; Godfrey 
et al., 2010). NKT cells characteristically express 
high levels of the BTB-POZ transcription factor   
promyelocytic leukemia zinc finger (PLZF) en-
coded by the gene Zbtb16, which is not only 
necessary for their effector differentiation but can 
also transfer this program upon ectopic (transgenic) 
expression in conventional MHC-restricted 
T cells (Kovalovsky et al., 2008, 2010; Raberger 
et al., 2008; Savage et al., 2008).
A majority of NKT cells recognize the same 
microbial lipids characterized by a galactose in 
 linkage to a ceramide or a diacylglycerol back-
bone (Kinjo et al., 2005, 2006; Mattner et al., 
2005; Sriram et al., 2005). They also recognize 
the self glycosphingolipid isoglobotrihexosyl-
ceramide (iGb3; Zhou et al., 2004). Other self- 
and foreign lipids have been identified as ligands 
for a smaller fraction of NKT cells (Fox et al., 
2009). NKT cells are not only involved in micro-
bial defense, as expected, but they also contribute 
to immune responses during viral infections, 
cancer, and various inflammatory and allergic 
states (Brigl and Brenner, 2004; Godfrey and 
Kronenberg, 2004). In some cases where patho-
gens do not appear to express ligands for direct 
NKT cell recognition, it has been demonstrated 
that the endogenous ligand iGb3 is up-regulated 
through toll-like receptor–mediated down-
regulation of its lysosomal degrading enzyme 
-galactosidase A (Darmoise et al., 2010).
The  homing  and  recirculation  patterns  of 
NKT cells are unique among T or B cell lineages. 
It has long been known that NKT cells are par-
ticularly abundant among liver lymphocytes 
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Innate-like NKT cells conspicuously accumulate within the liver microvasculature of healthy 
mice, crawling on the luminal side of endothelial cells, but their general recirculation pattern 
and the mechanism of their intravascular behavior have not been elucidated. Using parabiotic 
mice, we demonstrated that, despite their intravascular location, most liver NKT cells failed 
to recirculate. Antibody blocking experiments established that they were retained locally 
through constitutive LFA-1–intercellular adhesion molecule (ICAM) 1 interactions. This 
unprecedented lifelong intravascular residence could be induced in conventional CD4 T cells 
by the sole expression of promyelocytic leukemia zinc finger (PLZF), a transcription factor 
specifically expressed in the NKT lineage. These findings reveal the unique genetic and bio-
chemical pathway that underlies the innate intravascular surveillance program of NKT cells.
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of liver NKT cells into the peripheral blood, demonstrating 
the critical role of these integrins in the long-term intravas-
cular residence of NKT cells. These unusual properties could 
be transferred to conventional T cells by ectopic expression 
of PLZF, the signature transcription factor of the NKT cell 
lineage. Thus, PLZF directs a broad innate effector lympho-
cyte program where homing and recirculation properties 
are optimized to rapidly confront bloodborne, lymph-borne, 
or airborne pathogens in different tissues.
RESULTS
Intravascular compartments of NKT cells
Fig. 1 A illustrates the well known heterogeneous tissue dis-
tribution of CD1d--galactosylceramide+ (-GalCer) NKT 
cells in C57BL/6 mice, shown as percentage of CD3+ T cells, 
with particular accumulation in the liver but also spleen, bone 
marrow, and lung compared with peripheral lymph nodes and 
peripheral blood. The frequency of NKT cells in the latter 
compartments is low at 0.2% of T cells on average, reflecting 
the down-regulation of CD62L expression in these effector-
type cells. However, when blood was collected from portal and 
hepatic veins, using a needle directed toward the liver and 
mounted on a syringe for aspiration, 25% of T cells on aver-
age were NKT cells. Blood similarly collected from right and 
left heart ventricles, which connect to the pulmonary artery 
and vein, respectively, was 10–20× enriched in NKT cells 
compared with peripheral blood. These high frequencies sug-
gest that the accumulation of NKT cells in the microvascular 
compartment, previously established for the liver (Geissmann 
et al., 2005), may be observed in other organs such as the 
lungs. These accumulated blood NKT cells were mainly CD4+, 
whereas those in the peripheral blood were mostly CD4 
(Fig. 1 C). Further proof that the high concentration of NKT 
cells in blood drawn from portal vein was of hepatic rather 
than portal origin was obtained by placing a clamp near the 
hilum of the liver and drawing blood from the portal system 
with the needle pointing away from the liver. The frequency 
of NKT cells in portal blood was <1% on average (Fig. 1 D). 
A similar frequency was observed in the superior mesenteric 
vein, which drains into the portal vein.
Anatomical location of NKT cells in secondary lymphoid tissues
The anatomical location of NKT cells in spleen and lymph 
node was investigated using a CD1d--GalCer tetramer-based 
staining method to visualize these cells in V14-J18 TCR- 
transgenic mice. Fig. 2 shows that NKT cells were present in 
the T cell zone of the lymph node and in the periarteriolar 
sheath of the spleen, along with other TCR-+ cells, but rarely 
found in the B cell follicles, in the microvasculature, or in the 
red pulp. This picture was consistent with results observed in 
tissues of nontransgenic mice, although the low natural fre-
quency of NKT cells in these mice made it difficult to ascertain 
every individual cell stained by the tetramer method (unpub-
lished data). Thus, NKT cells in secondary lymphoid tissues 
are mostly extravascular and located in the T cell zone among 
conventional T cells.
(Ohteki and MacDonald, 1994), but only recently was their 
peculiar location and motility revealed by intravital imaging. In 
CXCR6-GFP knockin mice, GFPbright cells, which are mostly 
NKT cells, were found to crawl on the luminal surface on 
sinusoidal endothelial cells without directional bias at a speed 
of 10 µm/min (Geissmann et al., 2005). Thus, NKT cells are 
particularly well suited to intercept bloodborne pathogens such 
as Borrelia that are inoculated through tick bite and whose lipid 
antigens can be displayed by CD1d-expressing Kupffer cells 
in the liver sinusoids (Lee et al., 2010). Ehrlichia is another 
bacterial genus inoculated by tick bites and specifically recog-
nized by NKT cells in a CD1d-dependent manner (Mattner 
et al., 2005). This early innate interaction between NKT cells 
and Kupffer cells contributes to the formation of infectious 
granulomas. The location of NKT cells in other tissues, how-
ever, has remained obscure as a result of their relative rarity and 
the lack of a reliable staining method. In vitro CFSE-labeled 
and reinjected NKT cells were seen in the interfollicular region 
of the lymph node (Barral et al., 2010), but the isolation pro-
cedure using TCR reagents likely induced some activation and 
may have altered homing. The location of NKT cells within the 
spleen and lung has not been elucidated.
The mechanisms underlying the adhesion and crawling 
behavior of NKT cells in the liver sinusoids are not well under-
stood. In particular, CXCR6-deficient NKT cells normally 
homed to the liver, although they exhibited decreased survival 
(Geissmann et al., 2005) or function (Shimaoka et al., 2007; 
Germanov et al., 2008). LFA-1–deficient mice exhibited a se-
lective and profound decrease in liver NKT cells, but whether 
LFA-1 was required for liver retention of normal NKT cells 
or for the development of liver-tropic NKT cells was debated 
(Emoto et al., 1999; Ohteki et al., 1999). Mice deficient in 
the LFA-1 ligand intercellular adhesion molecule (ICAM) 1 did 
not show a corresponding decrease (Emoto et al., 1999; Ohteki 
et al., 1999) and blocking experiments using anti–LFA-1 and 
anti–ICAM-1 antibodies have not been reported. Although 
NKT cells express an unusual pattern of chemokine receptors 
and integrins, no other chemokine receptor or integrin defi-
ciencies have been associated with a specific NKT cell defect 
and surprisingly little is known about their homing pattern and 
recirculation dynamics (Johnston et al., 2003; Thomas et al., 
2003, 2007; Geissmann et al., 2005; Shimaoka et al., 2007; 
Semmling et al., 2010).
In this study, we generated parabiotic mouse pairs to in-
vestigate the dynamics of NKT cell exchange and recircula-
tion and we adapted a tetramer staining method to stain NKT 
cells in different tissues. Our findings demonstrate that most 
NKT cells were located in the T cell zones of lymphoid tissues 
but, unlike other T cells, they did not recirculate and instead 
established very long-term residence in these locations. In the 
liver, despite their location inside the sinusoid capillaries, NKT 
cells also failed to exchange over a period of 2 mo, implying 
that they largely restricted their movements within the confines 
of the liver capillary bed. A similar intravascular residence pat-
tern was demonstrated in the lung. Injection of blocking anti-
bodies against LFA-1 and ICAM-1 induced the rapid release JEM Vol. 208, No. 6 
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NKT cells in liver and lung, but also in lymphoid 
tissues such as spleen, lymph node, and bone marrow, 
failed to recirculate even after 8 wk. Thus, parabi-
otic mice harbored <5–10% congenic NKT cells 2 mo 
after surgery. In contrast, the peculiar population of 
CD4 NKT cells found in the peripheral blood rap-
idly equilibrated. Thus, NKT cells in organs and in 
lymphoid tissues appeared to be resident popula-
tions that did not exchange, even if they resided in-
side the vascular compartment.
The failure to recirculate could be related to the 
saturation of a putative NKT cell niche in the parabiotic part-
ner. However, in parabiosis experiments joining WT with 
CD1d-deficient mice, the CD1d-deficient partner also failed 
to attract WT NKT cells (Fig. 4 A). Likewise, NKT cells failed 
to populate TCR-C–deficient (lacking T cells) and RAG-c 
double-deficient (lacking T, B, NK, and other innate immune 
cells) parabionts, whereas conventional T cells and B cells 
quickly repopulated these “empty” mice.
NKT cell transfers
Because NKT cells do not spontaneously leave their tissue 
of residence, we extracted them from the spleen or liver of 
V14-J18 transgenic mice and intravenously injected them 
into CD45 congenic RAG KO hosts. To avoid any poten-
tial interference with the natural homing properties of these 
cells, they were not stained with TCR 
antibody or tetramer reagents which 
may  induce  significant  activation.   
Recirculation studies in parabiotic mice
To study the NKT cell recirculation pattern, we generated 
parabiotic mice with pairs of CD45.1 and CD45.2 congenic 
animals. During the healing process after surgery, capillary anas-
tomoses form between the two vascular systems, allowing for 
exchange of cells circulating in peripheral blood. Parabiotic 
mice were studied between 2 and 8 wk after surgery, a period 
during which bone marrow and thymic cell progenitors failed 
to exchange (Wright et al., 2001; Liu et al., 2007; for example, 
only 5% of double-positive thymocytes were of parabiotic 
partner origin at week 8 [not depicted]). As previously estab-
lished, conventional CD4 and CD8 T cells and B cells rapidly 
recirculated and equilibrated within 2 wk (Fig. 3). NK cells 
also largely recirculated in most tissues, although full exchange 
was not observed in liver and bone marrow. In marked contrast, 
Figure 1.  Tissue and blood distribution of NKT cells.  
(A and B) Representative dot plots pregated on B220-negative 
cells and showing tissue (A) and blood (B) V14 NKT cells 
identified as CD1d--GalCer tetramer+ CD3+ cells. Numbers 
show percentages of V14 NKT cells among CD3+ cells. Note 
that the blood samples of portal and hepatic vein, and right 
and left heart ventricles, were drawn by aspiration through a 
needle directed toward the liver and the lung, respectively.  
(C) Representative dot plots showing CD4 and NK1.1 expres-
sion by gated CD1d--GalCer tetramer+ CD3+ cells. Data are 
representative of three experiments with four to six mice per 
group. (D) Compilation of experiments showing the percentage 
of NKT cells among CD3+ cells recovered from tail vein and 
portal vein blood drawn as in B or from portal vein and supe-
rior mesenteric vein after clamping the portal vein at the liver 
hilum (clamp). Horizontal bars represent means.
Figure 2.  Anatomical location of NKT 
cells in mesenteric lymph node and spleen. 
Mesenteric lymph nodes (MLN) and spleens 
were harvested from J18 KO or V14-J18 
transgenic mice and frozen sections were 
stained with CD1d--GalCer tetramers in red, 
TCR- in blue, and B220 in green. Data are 
representative of three experiments with one 
mouse per group. Bars, 50 µm.1182 Mechanisms of NKT cell recirculation | Thomas et al.
liver (intravascular) NKT cells would exhibit dif-
ferential homing properties. Strikingly, splenic and 
liver NKT cells homed to both spleen and liver, irre-
spective of their origin (Fig. 4 B). These experiments 
suggest therefore that, whether extracted from the 
intravascular liver pool or the extravascular splenic 
pool, tissue-resident NKT cells home equally well to 
either location upon intravenous transfer.
Biochemical mechanism of intravascular residency
LFA-1–deficient mice exhibited a selective decrease 
in frequency of NKT cells in the liver and liver NKT 
cells expressed a very high level of LFA-1 compared 
with other CD4 T cells (Emoto et al., 1999). We 
confirmed the very high expression of LFA-1 in liver 
and found a similar pattern in the spleen (Fig. 5 A). How-
ever, we found that NKT cells recirculating in the periph-
eral blood had significantly lower LFA-1 levels, suggesting a 
In addition, to directly test for potential biases in tissue 
homing, we injected mixtures of CD45.1 splenic and CD45.2 
liver NKT cells, asking whether splenic (extravascular) and 
Figure 3.  Parabiotic mice do not exchange NKT cells. 
CD45.1 and CD45.2 congenic C57BL/6 mice joined in parabiotic 
pairs at 6 wk of age were examined 4 wk later (A and B) or at 
various time points as indicated (C). (A) Representative FACS 
dot plots from liver and from tail vein peripheral blood (PB) of 
the CD45.2 member of a parabiotic pair after 28 d of para-
biosis show the relative frequencies of CD45.2 (host) and CD45.1 
(parabiotic partner) cells among B (B220+ CD3), CD4 T 
(B220 CD3+ CD4+ CD1d--GalCer), CD8 T (B220 CD3+ 
CD8+), NK (NK1.1+ CD3), and V14 NKT (B220 CD3+ 
CD1d--GalCer+) cells. (B) Pie charts indicate the relative fre-
quencies of CD45.2 (black) and CD45.1 (gray) cells in each 
member of a representative parabiotic pair after 28 d. Data are 
shown for various lymphocyte subsets and tissues as indi-
cated. (C) Summary of chimerism for B (open square), CD4 T 
(filled triangle), CD8 T (open triangle), NK (filled circle), and 
V14 NKT (open circle) cells in the liver and spleen at different 
times after surgery for all parabionts. Each data point repre-
sents mean ± SEM. Days 14 and 28 are from two experiments 
with two parabiotic pairs per group and day 63 is from one 
experiment with two parabiotic pairs per group.
Figure 4.  NKT cell homing in empty mice and after intra-
venous transfer. (A) FACS dot plots show the V14 NKT cell 
percentage among CD45.1+ CD3+ liver cells 30 d after para-
biosis. The leftmost dot plot is from the WT CD45.1 parabiont and 
the four other dot plots are from CD45.2 parabionts of WT, CD1d 
KO, TCR- KO, and Rag-c double KO origin. Data are representa-
tive of three each of WT CD1d KO, WT TCR- KO, or WT Rag-c 
double KO parabiotic pairs. (B) A Rag1/ recipient of a mixture 
of liver (CD45.2) and splenic (CD45.1) cells from V14-J18 
transgenic (Tg) mice was analyzed after 2 wk. Lymphocytes har-
vested from spleen and liver were gated on CD3+ CD1d-- 
GalCer+ NKT cells and displayed in the CD45.1/CD45.2 dot plots, 
with rectangular gates showing the NKT cells of liver (CD45.2) and 
spleen (CD45.1) origin. Data are representative of one experiment 
where two individual Rag1/ recipient mice received mixtures 
containing 3.2–4.0 × 106 NKT cells:6.8–10.8 × 104 NKT cells were 
recovered in the liver and 1.0–1.3 × 104 NKT cells in the spleen.JEM Vol. 208, No. 6 
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whether  LFA-1  also  controlled  the  resident  phenotype  in 
lymphoid tissues. Characteristically, the cells released in 
the circulation were predominantly of the CD4+ phenotype 
found in tissue rather than in peripheral blood. No changes 
were observed after injection of anti–VLA-4 + anti–VCAM-1 
(Fig. 5 B).
As blockade of LFA-1–ICAM-1 interactions led to the 
release of liver-resident NKT cells into the blood circula-
tion, it was possible that the recirculating NKT cells might 
now reach the liver of a parabiotic partner. Indeed, parabi-
otic mice treated with the same anti–LFA-1 + anti–ICAM-1 
combination, but not isotype control, developed extensive 
recirculation between their liver NKT cell pools (Fig. 5 F). 
Thus, 2 wk after antibody treatment, although control iso-
type-treated parabiotic mice had only 4.6% of their liver 
NKT cells originating from the parabiotic partner, the pairs 
role for LFA-1 in the resident phenotype. To directly test the 
role of LFA-1 in vascular adhesion, we injected mice with 
various  anti-integrin  antibodies,  including  anti–LFA-1, 
ICAM-1, very late antigen (VLA) 4, and vascular cell adhe-
sion molecule (VCAM) 1 alone or in combinations. Modest 
but inconsistent drops of NKT cells in both relative fre-
quency and absolute number were observed in the liver with 
anti–LFA-1 but not the other antibodies (unpublished data). 
Next, we injected a combination of anti–LFA-1 and anti–
ICAM-1. Within 3 h, we observed a fivefold drop on aver-
age in the NKT cell numbers recovered from the liver (Fig. 5, 
B and C). This massive drop was accompanied by a 10-fold 
increase of the frequency of NKT cell in the peripheral recir-
culating blood, which now exceeded that of lymphoid tis-
sues (Fig. 5, D and E). Because of this massive release of liver 
NKT cells in the general circulation, it was not possible to test 
Figure 5.  LFA-1 controls the intravascular residence of liver NKT cells. (A) Representative dot plots gated on liver, spleen, and peripheral blood CD1d-
-GalCer+ V14 NKT cells and CD1d--GalCer CD4 T cells show LFA-1 (L2 integrin) staining. Data are representative of three experiments with two to 
four mice per group. In one such experiment, mean fluorescence intensity (MFI) ± SEM of CD11a (L) was 27,069 ± 553 for liver NKT, 25,725 ± 1741 for 
spleen NKT, and 16,574 ± 971 for peripheral blood NKT. Mean fluorescence intensity of CD18 (2) was 1,274 ± 194 for liver NKT, 680 ± 30 for spleen NKT, and 
419 ± 23 for peripheral blood NKT. The mean fluorescence intensities of CD11a and CD18 NKT cells in spleen and liver were significantly higher than in pe-
ripheral blood (P < 0.05). (B) Percentage of liver NKT lymphocytes 3 h after injection of either 200 µg isotype control antibody or 200 µg anti–LFA-1 + 100 µg 
anti–ICAM-1. Dot plots were gated on B220-negative cells. (C) Summary plot showing absolute numbers of liver CD4 T (excluding CD1d--GalCer+ cells) or 
V14 NKT cells in individual mice after treatment with antibodies as indicated. Horizontal bars represent means. Data shown are from one experiment and are 
representative of three experiments with two to four mice per group. (D) NKT lymphocytes in tail vein peripheral blood 3 h after injection of antibodies as in B. 
Dot plots in the top row are gated on B220 lymphocytes and show percentages of V14 NKT cells among CD3+ cells. Dot plots in the bottom row show  
the CD4 versus NK1.1 phenotype of gated NKT cells. Data are representative of two experiments with two to three mice per group. (E) Summary plot showing 
the percentage of CD4 T, CD8 T, and CD1d--GalCer+ NKT cells among CD3+ PBL in individual mice 3 h after injection of control or anti-integrin antibodies. 
Horizontal bars represent means. (F) Recirculation of liver NKT cells in parabiotic mice treated with a single injection of anti–LFA-1 + anti–ICAM-1, or isotype 
control and examined 2 wk later. Data are representative of three anti–LFA-1/ICAM-1–treated parabiotic pairs and two isotype-treated pairs.1184 Mechanisms of NKT cell recirculation | Thomas et al.
recirculated to the transgenic organs. Thus, PLZF expression 
not only induced high LFA-1 expression but also conferred 
the long-term tissue-resident phenotype upon expression in 
conventional CD4 T cells.
DISCUSSION
This paper reveals several unexpected characteristics of the 
recirculation and homing pattern of NKT cells and elucidates 
key biochemical and molecular mechanisms underlying these 
unusual properties. Although sinusoidal retention and crawling 
are well documented behaviors for many cell types, this mode 
of locomotion is transient, limited to the acute phase of im-
mune response for effector T cells (Bartholomäus et al., 2009), 
monocytes (Auffray et al., 2007), and PMNs (Phillipson et al., 
2006; McDonald et al., 2010) invading an organ or to a mat-
uration step for immature B cells in the bone marrow (Pereira 
et al., 2009). In the case of NKT cells (Geissmann et al., 2005), 
the results of the long-term parabiosis experiments presented 
in this study imply that this behavior can be prolonged for 
weeks and, therefore, that these innate-like lymphocytes con-
stitutively wander within the confines of the sinusoid capil-
lary bed of the liver for periods of time that can exceed their 
lifespan. This is consistent with their suggested role of vascu-
lar surveillance for blood-borne pathogens that are captured 
by Kupffer cells (Lee et al., 2010). Relevant examples of such 
pathogens include Borrelia and Ehrlichia (Mattner et al., 2005; 
Tupin et al., 2008), both of which are injected intravenously 
through tick bite. In addition, NKT cells can recognize lipids 
presented by CD1d-expressing hepatic stellate cells (Ito cells) 
and hepatocytes, which are easily accessible through the 
fenestrated capillaries of the liver (Winau et al., 2007).
Although direct visualization of NKT cells has not been 
reported in other organs, our findings support the notion that 
NKT cells also accumulate in the vascular compartment of the 
lung. Indeed, contrasting with a 0.2% frequency of NKT cells 
in peripheral tail vein, 2% of cells obtained through needle 
aspiration of the lung vascular system were NKT cells. Although 
this frequency is well below the extraordinary frequencies 
found in samples aspirated through the hepatic vein or the 
portal vein, it is consistent with a significant accumulation of 
NKT cells in the vascular compartment of the lung, with 
important implications for innate allergic responses in this organ. 
For example, we have recently found that airborne exposure 
to microbial NKT ligands resulted in rapid translocation of 
NKT cells from the vascular compartment to the lung inter-
stitium and bronchoalveolar space with subsequent recruit-
ment of eosinophils (unpublished data).
Cell adhesion and locomotion involves reversible binding 
between various integrins, such as LFA-1, Mac-1, VLA-4, 
LPAM-1 (lymphocyte Peyer’s Patch adhesion molecule 1), and 
their endothelial receptor ICAMs, VCAM-1, and MAdCAM-1 
(mucosal vascular addressin cell adhesion molecule 1). Our 
results clearly identify LFA-1 and ICAM-1 as major media-
tors of the endothelial adhesion of NKT cells. Although block-
ing of either LFA-1 or ICAM-1 alone had little effect on liver 
NKT cells, the combination resulted in rapid release of liver 
treated with anti–LFA-1 + anti–ICAM-1 had 47% on aver-
age. These results establish that LFA-1 and ICAM-1 are key 
integrins mediating the adhesion to sinusoidal cells and strongly 
suggest, therefore, that the very high levels of LFA-1 consti-
tutively expressed by NKT cells cause their long-term residence 
in the liver.
The transcription factor PLZF is sufficient to induce LFA-1 
up-regulation and liver accumulation of NKT cells
PLZF transgenic mice expressing the signature transcription 
factor PLZF under the cd4 promoter exhibit a massive conver-
sion of naive MHC class II–restricted CD4 T cells into effec-
tor cells capable of producing both IL-4 and IFN- (Savage 
et al., 2008). This effector conversion, which occurred during 
thymic development, was not accompanied by cell division and 
was associated with a redirection of CD4 cells from lymph 
node and blood to tissues. We examined adhesion receptors 
and found that PLZF transgenic CD4 T cells also uniformly 
overexpressed LFA-1 (Fig. 6 A). To test whether, like natural 
NKT cells, PLZF transgenic CD4 cells were resident rather than 
recirculating cells, we generated parabiotic pairs between 
WT and PLZF transgenic mice. Fig. 6 B shows that the trans-
genic CD4 T cells did not recirculate to the WT organs, 
whereas, in marked contrast, the WT CD4 T cells promptly 
Figure 6.  PLZF induces high LFA-1 expression and long-term tissue 
residence. (A) Dot plots gated on liver and spleen CD4 T (excluding CD1d-
-GalCer+ cells) show LFA-1 (L2 integrin) staining in WT or PLZF trans-
genic mice. Data are representative of one experiment with two mice per 
group. (B) Parabiotic pairs joining CD45.1 PLZF transgenic (Tg) and CD45.2 
WT mice. Dot plots show the CD45.2 and CD45.1 staining of gated B, CD4 T, 
CD8 T, and V14 NKT cells in the liver of the WT parabiont (top row) or the 
PLZF transgenic parabiont (bottom row) after 25 d of parabiosis. Data are 
representative of one experiment with two pairs of parabiotic mice.JEM Vol. 208, No. 6 
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provided. A previous study showed that purified and reinjected 
CFSE-labeled NKT cells migrated to the paracortical region 
of the lymph node (Barral et al., 2010), a result which seemed 
to be in conflict with the remarkable endothelial adhesion and 
intravascular location of NKT cells in the liver. In the para-
cortical location, NKT cells adopted a random walk (Barral 
et al., 2010) different from their crawling behavior on the sur-
face of endothelial cells in the liver microvasculature (Geissmann 
et al., 2005). One potential caveat in these experiments was 
the need to stain NKT cells with CD1d tetramer or anti–
TCR- antibody for purification before in vivo injection. 
The resulting TCR cross-linking might have induced some 
activation and changed the properties of NKT cells. Our spe-
cific staining in tissue section with CD1d tetramers not only 
confirmed that NKT cells did preferentially reside in the T cell 
zone of the lymph node and were conspicuously absent from 
the B cell follicles but also extended this observation to the 
spleen. This type of anatomical location is well suited for imme-
diate responses to microbial ligands brought to the draining 
lymph node (Barral et al., 2010) and is consistent with their 
innate mission of rapid response to microbial invasion.
The presence of noncommunicating pools of NKT cells 
with such drastic differences in location and locomotion, as 
found in the liver microvasculature and in the lymphoid or-
gans, raises the question of whether they belong to different 
specialized subsets or whether they represent essentially the 
same population with a flexible behavior in distinct environ-
ments. Our transfer experiments using mixtures of splenic and 
hepatic NKT cells clearly demonstrated that NKT cells in these 
locations had a similar ability to colonize either tissue. How-
ever, other studies have highlighted the existence of tissue-
specific NKT cell subsets. For example, NKT cells in peripheral 
lymph nodes stably expressed retinoic acid receptor–related 
orphan receptor t and produced IL-17 (Doisne et al., 2009), 
and a subset of splenic and lung NKT cells expressed the IL-25 
receptor (Terashima et al., 2008). Thus, as different genetic 
subprograms may be associated with NKT cells in different 
tissues, it is possible that NKT cells in some locations would 
exhibit special homing and adhesion properties.
Finally, our studies identified PLZF, the signature tran-
scription factor of NKT cells (Kovalovsky et al., 2008; Savage 
et al., 2008), as an essential inducer of their homing and 
adhesion behavior. Thus, whereas PLZF-deficient mice lacked 
liver NKT cells (Kovalovsky et al., 2008; Savage et al., 2008), 
the current study shows that PLZF transgenic conventional 
CD4 T cells not only acquired the very high LFA-1 expression 
pattern but also demonstrated the same liver-resident phenotype 
as NKT cells. These findings indicate that PLZF genetically 
controls the vascular surveillance program of NKT cells, at 
least in part through the induction of high level of LFA-1.
In summary, this study demonstrates that NKT cells ex-
hibit constitutive LFA-1–ICAM-1–mediated interactions that 
underlie a unique lifelong patrolling behavior within the con-
fines of the microcirculation of the liver and likely also the 
lung. Together with their rapid cytokine and chemokine re-
sponses, this property makes them uniquely positioned for 
NKT cells into the peripheral circulating blood. In contrast, 
blocking with anti–VLA-4 and anti–VCAM-1, which play a 
substantial role in the intraluminal crawling and transmigra-
tion of conventional effector T cells (Bartholomäus et al., 2009), 
had no effect. The release of liver NKT cells was seen as early 
as 30 min after injection and was complete by 3 h, as indicated 
by a loss of liver NKT cells and a >10-fold corresponding 
increase of their frequency in the peripheral blood. Further-
more, a single injection of anti–LFA-1 and anti–ICAM-1 was 
sufficient to induce extensive recirculation of NKT cells 
between parabiotic mice, as judged by the near equilibration 
achieved in the liver 2 wk after antibody blockade.
Integrin-mediated adhesion typically relies on inside-out 
activation, for example by signaling through chemokine mole-
cules arrayed on the surface of endothelial cells or by TCR 
signaling (Gomez-Rodriguez et al., 2007; Abram and Lowell, 
2009). In the case of NKT cells, the precise mechanisms en-
abling these interactions remain to be elucidated. Notably, 
previous studies based on transgenic expression of CD1d in 
the thymus only, or on NKT cell transfer into CD1d-deficient 
hosts, showed normal accumulation in the liver (McNab 
et al., 2005; Wei et al., 2005), implying that CD1d recogni-
tion, and therefore TCR stimulation, is not a prerequisite for 
sinusoidal retention. Crawling was also unimpeded in mice 
treated with anti-CD1d antibody (Lee et al., 2010). An alter-
native possibility is that chemokines constitutively arrayed on 
the luminal side of liver endothelial cells in the healthy state 
might maintain LFA-1 activation. However, neither genetic 
ablation of CXCR6, the major chemokine receptor expressed 
by NKT cells, nor treatment with pertussis toxin, an in-
hibitor of most G protein–coupled chemoreceptors, could 
induce the detachment of NKT cells from the liver microvas-
culature (Geissmann et al., 2005; Lee et al., 2010). Notably, 
NKT cells also normally accumulated in the liver of germ-free 
mice, ruling out a requirement for microbial exposure (Park 
et al., 2000).
Although the NKT cells present in tissues did not re-
circulate, those in the peripheral blood readily equilibrated in 
parabiotic mice. This apparent paradox may be explained by 
two observations. First, the circulating NKT cells had mostly 
a CD4-negative phenotype, whereas the tissue-resident cells 
were mostly CD4+, suggesting that they belonged to different 
subsets. Second, of relevance to the mechanism of vascular 
residence, circulating NKT cells expressed significantly fewer 
LFA-1 receptors than their tissue-resident counterparts. In any 
case, this observation supports the emerging heterogeneity 
of NKT cells, as pointed out recently (Godfrey et al., 2010), 
and raises further caution about the representative value of 
human studies that are restricted to the circulating pool of 
NKT cells.
Our study also clarifies the anatomical location of NKT 
cells in secondary lymphoid tissues. A previous study suggested   
a clustering of eGFP+ TCR-+ cells, presumably including 
NKT cells, in the periarteriolar lymphoid sheath of 4get mice 
after injection of anti-CD3 antibody (Stetson et al., 2003), but 
a direct identification of NKT cells before stimulation was not 1186 Mechanisms of NKT cell recirculation | Thomas et al.
lower abdomen on opposing sides of each member of the pair. Animals were 
placed side by side and skin edges sewn together.
Adoptive transfer of NKT cells. Single cell suspensions from liver and 
spleen of CD45.2 and CD45.1 V14-J18 transgenic mice, respectively, were 
isolated by centrifugation over Lympholyte and mixed at 1:2 ratio of V14 
NKT cells. 20 × 106 cells of the mixture (containing 4 × 106 NKT cells) were 
injected i.v. into C57BL/6.Rag1/ hosts.
Blocking  antibody  experiments.  Blocking  antibodies  against  mouse 
CD11a (LFA-1; M17/4), CD54 (ICAM-1; YNI.7.4), CD49d (VLA-4; PS/2), 
and CD106 (VCAM-1; M/K-2.7) and rat IgG2a Control (2A3) were pur-
chased from BioXCell and injected iv 3 h before tissue harvest. Injections 
consisted of 200 µg isotype control antibody, 100 µg anti–LFA-1, 200 µg anti–
ICAM-1, 100 µg VLA-4, or 200 µg VCAM-1 blocking antibodies. These 
quantities were based on previously determined saturating antibody concen-
trations (Pereira et al., 2009).
Statistical analysis. Statistical analysis was performed in Prism (GraphPad 
Software) with the unpaired Student’s t test.
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rapid response within the infected organ itself, as recently 
visualized in the context of infection by Borrelia (Lee et al., 
2010). Because this behavior can be induced through the ex-
pression of PLZF alone, our study emphasizes the central role 
of this signature transcription factor in orchestrating the com-
plex functional and circulatory properties that characterize 
innate-like effector T cells.
MATERIALS AND METHODS
Mice. C57BL/6 (Ly5.2), B6.SJL-PtprcaPep3b/BoyJ (CD45.1), CD1d-
deficient (Cd1d1/Cd1d2/), TCR-–deficient (tcra/), and Rag-1/ mice 
in the C57BL/6 background were purchased from The Jackson Laboratory. 
C57BL/6 Rag-c double-deficient (Rag2/ il2rg/) mice were obtained 
from Taconic. C57BL/6 J18/ mice were obtained from M. Taniguchi 
(Riken Research Center for Allergy and Immunology, Yokohama, Japan; Cui 
et al., 1997). V14-J18 TCR- transgenic mice (Griewank et al., 2007) and 
PLZF transgenic mice (driven by the cd4 promoter) were described previously 
(Savage et al., 2008). Unless otherwise stated, 6–10-wk-old mice were used in 
experiments. All mice were raised in a specific pathogen-free environment at 
the University of Chicago, and experiments were performed in accordance 
with the guidelines of the Institutional Animal Care and Use Committee.
Antibodies and flow cytometry. CD1d--GalCer tetramers were pre-
pared as previously described (Benlagha et al., 2000). Primary or fluoro-
chrome-labeled monoclonal antibodies for flow cytometry against mouse 
B220 (RA3-6B2), CD1d (1B1), CD3 (17A2), CD4 (RM4-5), CD8 (53–
6.7), CD11a (2D7), CD18 (M18/2), CD24 (M1/69), CD29 (HM1-1), 
CD44 (IM7), CD41 (MWReg30), CD45.1 (A20), CD45.2 (104), CD49a 
(Ha31/8),  CD49b  (DX5),  CD49d  (9C10  [MFR4.B]  or  R1-2),  CD49e 
(5H10-27  [MFR5]),  CD49f  (GoH3),  CD51  (RMV-7),  CD61  (2C9.G2 
[HM3-1]), CD62L (MEL-14), CD104 (346-11A), LPAM-1 (DATK32), 
NK1.1 (PK136), and TCR- (H57-597) were purchased from eBioscience, 
BD, or BioLegend. Samples were collected on a LSRII (BD) using FACS-
Diva software (BD), and data were analyzed using FlowJo (Tree Star).
Single cell preparation. Blood was either isolated from tail vein or was as-
pirated into a syringe through a needle inserted into the portal, hepatic, left, 
or right ventricle, with the needle directed toward the liver or the lung, re-
spectively, while mice were anesthetized with 100 mg/kg ketamine and 
10 mg/kg xylazine. Lung and liver were perfused with PBS, harvested, minced, 
and digested for 30 min in RPMI with Blendzyme 3 (Roche) and DNase 
(Roche) at 37°C. The remaining cell slurry was strained through 70-µm 
mesh and pelleted by centrifugation. The cell pellet was resuspended in 44% 
Percoll, layered over 66% Percoll gradient, and spun at 600 g. Bone marrow 
was isolated by flushing bones with RPMI. Spleen, thymus, and lymph node 
cells were isolated by pressing through cell strainers.
Immunofluorescence  and  microscopy.  Mesenteric  lymph  nodes  and 
spleen were placed in Tissue-Tek OCT and were flash frozen on dry ice and 
stored at 80°C. Cryostat sections 7 mm in thickness were transferred to 
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3 anti–Armenian hamster (1:1,000; Jackson ImmunoResearch Laboratories), 
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anti–rat (1:500; Jackson ImmunoResearch Laboratories) and then washed, and 
Prolong Gold (Invitrogen) was added to slides plus coverslip. Note that a criti-
cal aspect of this procedure was the immediate processing of the staining reac-
tion in the absence of fixation. Tissue was analyzed on a microscope (DM 
IRE2; Leica) with a digital camera (ORCA-ER; Hamamatsu).
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